Showing results (361-370 of 477) with videos related to

Sort By:
Pageof 48
Journal of Evaluation in Clinical Practice|February 1, 2011
Evidence-based medicine training in a resource-poor country, the importance of leveraging personal and institutional relationshipsCristina Tomatis, Claudia Taramona, Emiliana Rizo-Patrón, et al.
The American Journal of the Medical Sciences|April 5, 2013
Evaluation of an advanced physical diagnosis course using consumer preferences methods: the nominal group techniqueJoshua Coker, Analia Castiglioni, Ryan R Kraemer, et al.
The Journal of Physiology|March 4, 2023
Antagonism of TRPV4 channels partially reduces mechanotransduction in rat skeletal muscle afferentsAyumi Fukazawa, Amane Hori, Norio Hotta, et al.
Cytotherapy|August 26, 2024
Enhancing photodynamic and radionuclide therapy by small interfering RNA (siRNA)-RAD51 transfection via self-emulsifying delivery systems (SNEDDS)Ulises Paredes-Hernández, Leslie V Aguilar-Peña, Keila Isaac-Olivé, et al.
Molecular Diversity|April 25, 2020
Molecular modeling and LC-MS-based metabolomics of a glutamine-valproic acid (Gln-VPA) derivative on HeLa cellsM J Fragoso-Vázquez, D Méndez-Luna, M C Rosales-Hernández, et al.
Blood|May 16, 2023
Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitorKenneth C Childers, Nathan G Avery, Kevin A Estrada Alamo, et al.
Parasitology Research|December 23, 2022
A monoclonal antibody against a Leishmania mexicana COX-like enzymatic activity also recognizes similar proteins in different protozoa of clinical importanceVerónica I Hernández-Ramírez, Luis A Estrada-Figueroa, Yolanda Medina, et al.
The Journal of Continuing Education in the Health Professions|December 10, 2009
Characteristics that predict physician participation in a Web-based CME activity: the MI-Plus studyMichael J Schoen, Edmond F Tipton, Thomas K Houston, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 15, 2019
A 3-(4-nitronaphthen-1-yl) amino-benzoate analog as a bifunctional AKR1C3 inhibitor and AR antagonist: Head to head comparison with other advanced AKR1C3 targeted therapeuticsPhumvadee Wangtrakuldee, Adegoke O Adeniji, Tianzhu Zang, et al.
Pageof 48